Merck & Co., Inc. (NEO:MRK)

Market Cap	272.43B
Revenue (ttm)	91.88B
Net Income (ttm)	25.06B
Shares Out	n/a
EPS (ttm)	9.89
PE Ratio	10.87
Forward PE	8.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,149
Average Volume	9,747
Open	18.14
Previous Close	18.06
Day's Range	17.87 - 18.16
52-Week Range	16.84 - 22.39
Beta	n/a
RSI	47.50
Earnings Date	Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1891
• Employees: 75,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD